Salivary biomarkers are indicators found in saliva that reflect various physiological and pathological conditions in the human body. These biomarkers offer a non-invasive and easily accessible means for monitoring health. Saliva contains a diverse range of substances, including proteins, hormones, and nucleic acids, which can serve as diagnostic markers for diseases such as diabetes, cancer, and infectious diseases. Researchers are increasingly exploring salivary biomarkers as a convenient and cost-effective alternative to traditional blood tests. The study of salivary biomarkers, known as salivaomics, has gained prominence in recent years due to advancements in analytical techniques and the understanding of saliva's diagnostic potential. Salivary diagnostics hold promise for early disease detection, personalized medicine, and monitoring treatment responses. Notably, saliva can provide real-time information about a person's health status. As a non-invasive and stress-free collection method, saliva sampling is particularly advantageous, especially in pediatric and geriatric populations. Recent research has identified specific salivary biomarkers associated with conditions such as cardiovascular diseases, neurodegenerative disorders, and oral health. This growing field has the potential to revolutionize healthcare by enabling point-of-care testing and enhancing disease management strategies. The development of reliable salivary biomarker assays and the integration of these markers into routine clinical practice could usher in a new era of personalized and preventive medicine.
Title : The impact of AI on the future of public health and preventative healthcare
David John Wortley, International Society of Digital Medicine (ISDM), United Kingdom
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Managing integration and interoperability of intelligent and ethical transformed health and social care ecosystems
Habil Bernd Blobel, University of Regensburg, Germany
Title : Study scalp electroacupuncture therapy for autism spectrum disorder
Zhenhuan Liu, University of Chinese Medicine, China
Title : Environmental Public Health Impact Assessment (EHIA) process for tobacco processing plants
Vijayan Gurumurthy Iyer, Techno-Economic- Environmental Study and Check Consultancy Services, India
Title : Therapeutic potential of Benincasa hispida extract in regulating metabolic markers among patients with type 2 diabetes
Wan Rosli Wan Ishak , University Science Malaysia, Malaysia